Literature DB >> 14715327

Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus).

Ross T Tsuyuki1, Kari L Olson, Alexander M Dubyk, Terri J Schindel, Jeffrey A Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14715327     DOI： 10.1016/j.amjmed.2003.09.024

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  10 in total

1.  Putting cardiovascular risk into perspective: A view from a pharmacist patient.

Authors:  Tom Smiley
Journal:  Can Pharm J (Ott)       Date:  2013-03

2.  A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study.

Authors:  Julie Villeneuve; Jacques Genest; Lucie Blais; Marie-Claude Vanier; Diane Lamarre; Marc Fredette; Marie-Thérèse Lussier; Sylvie Perreault; Eveline Hudon; Djamal Berbiche; Lyne Lalonde
Journal:  CMAJ       Date:  2010-03-08       Impact factor: 8.262

3.  Designing a novel continuing education program for pharmacists: Lessons learned.

Authors:  Barbara Farrell; Lisa Dolovich; Phil Emberley; Marie-Anik Gagné; Brad Jennings; Derek Jorgenson; Natalie Kennie; Pia Zeni Marks; Christine Papoushek; Nancy Waite; Donna M M Woloschuk
Journal:  Can Pharm J (Ott)       Date:  2012-07

4.  Impact of an interactive workshop on community pharmacists' beliefs toward patient care.

Authors:  Lisa M Guirguis; Shao Lee; Ravina Sanghera
Journal:  Int J Clin Pharm       Date:  2012-04-17

5.  An Elective Course to Train Student Pharmacists to Deliver a Community-based Group Diabetes Prevention Program.

Authors:  Lisa J Woodard; Skye McKennon; Jennifer Danielson; Judy Knuth; Peggy Odegard
Journal:  Am J Pharm Educ       Date:  2016-08-25       Impact factor: 2.047

6.  Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.

Authors:  Steven M Edworthy; Bonnie Baptie; Donna Galvin; Rollin F Brant; Terry Churchill-Smith; Dante Manyari; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

7.  Role of community pharmacists in the prevention and management of the metabolic syndrome in Kuwait.

Authors:  Maram G Katoue; Abdelmoneim I Awad; Samuel B Kombian
Journal:  Int J Clin Pharm       Date:  2012-10-16

8.  Assessing Medicare Beneficiary Eligibility for Medication Therapy Management Programs Using PINNACLE, a National Cardiovascular Data Registry.

Authors:  Sarah A Spinler; Mark J Cziraky; Fengming Tang; Gladys G Dueñas; Tyan Thomas; Jennifer A Reinhold; Vincent J Willey
Journal:  Am Health Drug Benefits       Date:  2013-09

9.  Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP).

Authors:  Charlotte Jones; Scot H Simpson; Diana Mitchell; Susan Haggarty; Norman Campbell; Karen Then; Richard Z Lewanczuk; Rolf J Sebaldt; Barbara Farrell; Lisa Dolovitch; Janusz Kaczorowski; Larry W Chambers
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

10.  Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.

Authors:  Liz Steed; Ratna Sohanpal; Adam Todd; Vichithranie W Madurasinghe; Carol Rivas; Elizabeth A Edwards; Carolyn D Summerbell; Stephanie Jc Taylor; R T Walton
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.